TITANBIO.BO
Price
Day trading desk
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
3 more panels on TITANBIO.BO open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Valuation & profitability ratios
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $2.06B | $1.56B | $1.64B | $1.44B | — | +31.8% |
| Operating revenue | $2.06B | $1.56B | $1.64B | $1.44B | — | +31.8% |
| Cost of revenue | $961.95M | $726.28M | $756.06M | $856.39M | — | +32.4% |
| Gross profit | $1.10B | $838.23M | $884.66M | $583.60M | — | +31.2% |
| Selling, general & admin | — | — | $111.61M | $96.37M | $65.66M | — |
| Total operating expense | $763.17M | $625.66M | $393.86M | $313.63M | — | +22.0% |
| Operating income | $336.78M | $212.57M | $309.51M | $269.97M | — | +58.4% |
| Net interest income | -$9.14M | -$8.02M | -$11.70M | -$7.02M | — | -14.0% |
| Pre-tax income | $381.75M | $243.67M | $315.29M | $281.16M | — | +56.7% |
| Tax provision | $107.27M | $60.96M | $78.66M | $70.91M | — | +76.0% |
| Net income | $298.85M | $215.32M | $248.53M | $248.44M | — | +38.8% |
| Net income to common | $298.85M | $215.32M | $248.53M | $248.44M | — | +38.8% |
| Basic EPS | 7.23 | 5.21 | 6.01 | 6.01 | — | +38.8% |
| Diluted EPS | 7.23 | 5.21 | 6.01 | 6.01 | — | +38.8% |
| EBIT | $390.88M | $251.69M | $324.68M | $286.80M | — | +55.3% |
| EBITDA | $440.14M | $293.39M | $357.99M | $312.80M | — | +50.0% |
| Basic shares | 41.33M | 41.33M | 41.32M | 41.32M | — | +0.0% |
| Diluted shares | 41.33M | 41.33M | 41.32M | 41.32M | — | +0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $14.78M | $51.28M | $28.40M | $48.64M | — | -71.2% |
| Cash & short-term investments | $18.73M | $51.28M | $28.40M | $48.64M | — | -63.5% |
| Accounts receivable | $228.29M | $188.16M | $186.58M | $210.08M | — | +21.3% |
| Inventory | $557.69M | $508.21M | $458.75M | $365.58M | — | +9.7% |
| Total current assets | $852.42M | $790.38M | $726.20M | $683.06M | — | +7.9% |
| Property, plant & equipment | $632.52M | $588.46M | $544.70M | $491.04M | — | +7.5% |
| Goodwill & intangibles | $839.00K | $1.22M | $950.00K | $852.00K | — | -31.3% |
| Total assets | $2.14B | $1.75B | $1.57B | $1.35B | — | +22.4% |
| Total current liabilities | $259.63M | $177.36M | $195.71M | $203.51M | — | +46.4% |
| Current debt | $33.44M | $19.18M | $67.18M | $67.00M | — | +74.4% |
| Long-term debt | $3.27M | $1.84M | $4.53M | $2.99M | — | +77.3% |
| Total debt | $57.07M | $27.97M | $83.03M | $85.12M | — | +104.1% |
| Total liabilities | $323.37M | $213.04M | $235.74M | $246.04M | — | +51.8% |
| Retained earnings | — | $1.36B | $1.16B | $928.21M | $759.86M | — |
| Shareholder equity | $1.82B | $1.53B | $1.33B | $1.10B | — | +18.3% |
| Working capital | $592.80M | $613.01M | $530.49M | $479.55M | — | -3.3% |
| Net tangible assets | $1.81B | $1.53B | $1.33B | $1.10B | — | +18.4% |
| Shares issued | 41.32M | 41.32M | 41.32M | 41.32M | — | 0.0% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $381.75M | $243.67M | $315.29M | $281.16M | +56.7% |
| Depreciation & amortisation | $49.25M | $41.70M | $33.31M | $26.00M | +18.1% |
| Change in working capital | -$63.97M | -$35.46M | -$72.77M | -$29.60M | -80.4% |
| Operating cash flow | $304.21M | $201.23M | $211.46M | $211.78M | +51.2% |
| Capital expenditure | -$93.13M | -$94.44M | -$196.90M | -$134.65M | +1.4% |
| Investing cash flow | -$344.15M | -$98.75M | -$203.04M | -$207.25M | -248.5% |
| Dividends paid | -$16.53M | -$16.53M | -$14.88M | -$12.40M | 0.0% |
| Financing cash flow | $3.44M | -$79.61M | -$28.66M | -$24.03M | +104.3% |
| Free cash flow | $211.07M | $106.79M | $14.57M | $77.14M | +97.6% |
| End cash position | $14.78M | $51.28M | $28.40M | $48.64M | -71.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $488.33M | $565.06M | $543.55M | $464.96M | $351.69M | -13.6% |
| Operating revenue | $488.33M | $565.06M | $543.55M | $464.96M | $351.69M | -13.6% |
| Cost of revenue | $188.29M | $273.68M | $260.49M | $239.50M | $150.13M | -31.2% |
| Gross profit | $300.04M | $291.38M | $283.06M | $225.47M | $201.57M | +3.0% |
| Total operating expense | $215.92M | $195.75M | $201.88M | $149.62M | $164.30M | +10.3% |
| Operating income | $84.13M | $95.62M | $81.18M | $75.85M | $37.27M | -12.0% |
| Net interest income | -$2.37M | -$2.57M | -$2.24M | -$1.95M | -$788.00K | +7.8% |
| Pre-tax income | $102.82M | $105.62M | $92.19M | $81.12M | $50.28M | -2.7% |
| Tax provision | $37.26M | $26.94M | $23.56M | $19.51M | $12.62M | +38.3% |
| Net income | $67.29M | $85.29M | $77.65M | $68.63M | $40.47M | -21.1% |
| Net income to common | $67.29M | $85.29M | $77.65M | $68.63M | $40.47M | -21.1% |
| Basic EPS | 1.63 | 2.06 | 1.88 | 1.66 | 0.98 | -21.0% |
| Diluted EPS | 1.63 | 2.06 | 1.88 | 1.66 | 0.98 | -21.0% |
| EBIT | $105.19M | $108.19M | $94.43M | $83.07M | $51.07M | -2.8% |
| EBITDA | $118.16M | $120.86M | $106.52M | $94.59M | $59.51M | -2.2% |
| Basic shares | 41.28M | 41.32M | 41.30M | 41.34M | 41.29M | -0.1% |
| Diluted shares | 41.28M | 41.32M | 41.30M | 41.34M | 41.29M | -0.1% |
| Line item | 2026-03-31 | 2025-09-30 | 2025-03-31 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $14.78M | $16.33M | $51.28M | -9.5% |
| Cash & short-term investments | $18.73M | $35.99M | $51.28M | -47.9% |
| Accounts receivable | $228.29M | $296.36M | $188.16M | -23.0% |
| Inventory | $557.69M | $456.19M | $508.21M | +22.2% |
| Total current assets | $852.42M | $898.37M | $790.38M | -5.1% |
| Property, plant & equipment | $632.52M | $599.96M | $588.46M | +5.4% |
| Goodwill & intangibles | $839.00K | $1.10M | $1.22M | -24.1% |
| Total assets | $2.14B | $2.02B | $1.75B | +5.6% |
| Total current liabilities | $259.63M | $322.89M | $177.36M | -19.6% |
| Current debt | $33.44M | $78.42M | $19.18M | -57.4% |
| Long-term debt | $3.27M | $2.48M | $1.84M | +31.9% |
| Total debt | $57.07M | $88.50M | $27.97M | -35.5% |
| Total liabilities | $323.37M | $360.71M | $213.04M | -10.4% |
| Shareholder equity | $1.82B | $1.66B | $1.53B | +9.1% |
| Working capital | $592.80M | $575.48M | $613.01M | +3.0% |
| Net tangible assets | $1.81B | $1.66B | $1.53B | +9.1% |
| Shares issued | 41.32M | 41.32M | 41.32M | 0.0% |
Newly listed companies often have nothing on file until their first annual report.
Analyst targets & ownership
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Headlines
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.